New avenues in breast cancer treatment: The role of ubiquitin-specific proteases in programmed cell death
Peer-Reviewed Publication
Updates every hour. Last Updated: 15-Jul-2025 17:11 ET (15-Jul-2025 21:11 GMT/UTC)
A breakthrough in lung cancer treatment may be on the horizon. Scientists at VCU Massey Comprehensive Cancer Center have uncovered a powerful combination therapy leveraging sotorasib—an FDA-approved drug in the market—and an experimental drug called FGTI-2734, which could make precision medicine more effective for patients with a highly resistant form of lung cancer. The study, featured on the cover of the Journal of Thoracic Oncology, reveals a potential game-changer for patients battling tumors with the KRAS G12C mutation—a driver in about 14% of non-small cell lung cancers.